NYU Langone Health recorded total revenue of $14.2 billion: 30.8% from inpatient operations; 28.1% from outpatient operations; 19.1% from faculty group practice patient services; and 22% from other sources. Total revenue increased by $1.8 billion or by 14.2% year over year.
Total operating expenses were $13.7 billion: 60.1% salaries and benefits; 32.3% pharmaceutical, medical, and other supplies; 6.0% depreciation and amortization; and 1.6% interest. Total expenses increased by $1.7 billion or 14% year over year.
Days cash on hand for NYU Langone decreased to 144 days on Aug. 31, 2024, compared to 164 days on Aug. 31, 2023. The decrease was primarily driven by capital expenditures to support strategic capital investments.
Net income for fiscal 2024 was $890.5 million, compared to $1.3 billion in fiscal 2023.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
